@axoaxonic
Holly,
A friend just linked me to the "Essential3" Ulixacaltamide study. You had mentioned the earlier phases in Nov 2023. I did the "qualification" test online and they said I fit. But when I go to the appointment page to setup an intake call, it says "No times available in February" and won't let me advance to March. Or provide any other contact route.
Searching the web for the Praxis company, it is all about other test failures and the stock price tanking from $20 to $1.
https://www.biopharmadive.com/news/praxis-tremor-trial-results/644117/
-----
Despite study setback, a biotech plans to push tremor drug into late-stage testing
The trial found the drug was no better than a placebo at improving patients’ condition, as measured by a scorecard used to evaluate the severity of their tremors as well as how they perform daily activities like speaking, writing and standing. However, Praxis said its drug showed small, but statistically significant improvements over placebo on three other scorecards that served as secondary goals of the study.
-----
The current Phase 3:
https://www.mdsabstracts.org/abstract/essential3-an-innovative-multi-study-phase-3-program-to-evaluate-the-efficacy-and-safety-of-ulixacaltamide/
The intake page:
https://essential3study.com/
Do I even want to be part of this? And maybe get a placebo while wasting lots of time with their representatives? If they will even bother coming out to my very rural location... When their results depend on silly questions about self perception, that disagree with each other?
#essentialTremor #tremor